<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">marinedrugs</journal-id>
      <journal-title>Marine Drugs</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Mar. Drugs</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Marine Drugs</abbrev-journal-title>
      <issn pub-type="epub">1660-3397</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/md10081662</article-id>
      <article-id pub-id-type="publisher-id">marinedrugs-10-01662</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Briareolate Esters from the Gorgonian <italic>Briareum asbestinum</italic></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Meginley</surname>
            <given-names>Rian J.</given-names>
          </name>
          <xref rid="af1-marinedrugs-10-01662" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>Prasoon</given-names>
          </name>
          <xref rid="af1-marinedrugs-10-01662" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schulz</surname>
            <given-names>Thomas C.</given-names>
          </name>
          <xref rid="af2-marinedrugs-10-01662" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McLean</surname>
            <given-names>Amanda B.</given-names>
          </name>
          <xref rid="af3-marinedrugs-10-01662" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Robins</surname>
            <given-names>Allan J.</given-names>
          </name>
          <xref rid="af2-marinedrugs-10-01662" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>West</surname>
            <given-names>Lyndon M.</given-names>
          </name>
          <xref rid="af1-marinedrugs-10-01662" ref-type="aff">1</xref>
          <xref rid="c1-marinedrugs-10-01662" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-marinedrugs-10-01662"><label>1</label> Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, FL 33431, USA; Email: <email>rmeginle@fau.edu</email> (R.J.M.); <email> pgupta2@fau.edu</email> (P.G.) </aff>
      <aff id="af2-marinedrugs-10-01662"><label>2</label> Viacyte Inc., 111 Riverbend Rd, Athens, GA 30602, USA; Email: <email>TSchulz@viacyte.com</email> (T.C.S.); <email>ARobins@viacyte.com</email> (A.J.R.)</aff>
      <aff id="af3-marinedrugs-10-01662"><label>3</label> Department of Biochemistry and Molecular Biology, The University of Georgia, Athens, GA 30602, USA; Email: <email>abeggs@uga.edu</email> </aff>
      <author-notes>
        <corresp id="c1-marinedrugs-10-01662"><label>*</label> Author  to whom correspondence should be addressed; Email: <email>lwest@fau.edu</email>; Tel.: +1-561-297-0939; Fax: +1-561-297-2759.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>10</day>
        <month>08</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection"><month>08</month>
        <year>2012</year>
      </pub-date>
      <volume>10</volume>
      <issue>8</issue>
      <fpage>1662</fpage>
      <lpage>1670</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>06</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>25</day>
          <month>07</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>07</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>©  2012 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>Two new briarane diterpenoids briareolate esters J (<bold>1</bold>) and K (<bold>2</bold>) were isolated from the methanolic extract of the octocoral <italic>Briareum asbestinum</italic> collected off the coast of Boca Raton, Florida. The structures of briaranes <bold>1</bold> and <bold>2</bold> were elucidated by interpretation of spectroscopic data. Briareolate ester K (<bold>2</bold>) showed weak growth inhibition activity against human embryonic stem cells (BG02).</p>
      </abstract>
      <kwd-group>
        <kwd>
          <italic>Briareum asbestinum</italic>
        </kwd>
        <kwd>octocoral</kwd>
        <kwd>briarane</kwd>
        <kwd>briareolate ester</kwd>
        <kwd>human embryonic stem cell</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>1. Introduction</title>
      <p>Gorgonian corals have provided an abundance of novel structures with many of these demonstrating potentially useful biological activities. The gorgonian <italic>Briareum asbestinum</italic> has shown to be a plentiful source of diterpenoids belonging to the eunicellin, asbestinane, cembrane, and briarane classes and display numerous biological activities (e.g., cytotoxicity, antimicrobial, anti-inflammatory, antiviral, immunomodulatory, antifouling, and ichthotoxicity) [<xref ref-type="bibr" rid="B1-marinedrugs-10-01662">1</xref>]. Briarane-type diterpenoids contain a highly oxidized bicyclo[8.4.0] system of which most contain a γ-lactone ring. The briareolate esters are a small group of briarane diterpenoids isolated from <italic>Briareum asbestinum</italic> that contain a C-19 methyl ester instead of the typical γ-lactone ring [<xref ref-type="bibr" rid="B2-marinedrugs-10-01662">2</xref>,<xref ref-type="bibr" rid="B3-marinedrugs-10-01662">3</xref>,<xref ref-type="bibr" rid="B4-marinedrugs-10-01662">4</xref>]. </p>
      <p>As part of an ongoing study to discover compounds that impact human embryonic stem cell (hESC) growth we have been screening pre-fractionated and semi-purified marine natural product extract libraries generated using a solid phase extraction (SPE) procedure followed by semi-preparative high pressure liquid chromatography (HPLC) using evaporative light scattering detection (ELSD) directed fractionation (<xref ref-type="fig" rid="marinedrugs-10-01662-f001">Figure 1</xref>). The cell growth inhibitory activities of the pre-fractionated extract libraries are then evaluated against human embryonic stem cells (BG02) using a 96-well plate real-time cell electronic sensing (RT-CES) system to identify compounds that impact self-renewal, differentiation or apoptosis. A plot of cell index (impedance) <italic>versus</italic> time is used to indicate relative proliferation, differentiation, or death in real-time (<xref ref-type="fig" rid="marinedrugs-10-01662-f002">Figure 2</xref>). </p>
      <p>Our previous work using this approach on <italic>B. asbestinum</italic> resulted in the isolation of three new briareolate esters L–N (<bold>3</bold>–<bold>5</bold>) [<xref ref-type="bibr" rid="B5-marinedrugs-10-01662">5</xref>]. This included the biologically active compound briareolate ester L (<bold>3</bold>) that was found to possess a 10-membered macrocyclic ring with a (<italic>E</italic>,<italic>Z</italic>)-dieneone and was shown to contain a “spring loaded” Michael acceptor that is capable of forming a reversible covalent bond to model sulfur-based nucleophiles. In the present study we report the isolation and structural elucidation of two additional new briarane diterpenoids briareolate esters J (<bold>1</bold>) and K (<bold>2</bold>), along with three known compounds from the methanolic extract of <italic>B. asbestinum</italic> that was found to exhibit growth inhibition against BG02 cells (<xref ref-type="fig" rid="marinedrugs-10-01662-f003">Figure 3</xref>).</p>
      <fig id="marinedrugs-10-01662-f001" position="anchor">
        <label>Figure 1</label>
        <caption>
          <p>HPLC chromatogram of the pre-fractionated extract of <italic>B. asbestinum</italic> showing the fractions separated using ELSD-directed collection to generate a semi-purified extract library for biological screening.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="marinedrugs-10-01662-g001.tif"/>
      </fig>
      <fig id="marinedrugs-10-01662-f002" position="anchor">
        <label>Figure 2</label>
        <caption>
          <p>A cell index <italic>vs.</italic> time plot for a pre-fractionated extract library of <italic>B. asbestinum</italic> against the BG02 cell line. A drop in cell index within the first 24–48 h after addition of the compounds is interpreted as toxicity or induction of apoptosis.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="marinedrugs-10-01662-g002.tif"/>
      </fig>
      <fig id="marinedrugs-10-01662-f003" position="anchor">
        <label>Figure 3</label>
        <caption>
          <p>Structures of compounds <bold>1</bold>–<bold>7</bold>.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="marinedrugs-10-01662-g003.tif"/>
      </fig>
    </sec>
    <sec sec-type="results">
      <title>2. Results and Discussion</title>
      <p>Specimens of <italic>Briareum asbestinum</italic> (<xref ref-type="fig" rid="marinedrugs-10-01662-f004">Figure 4</xref>) were collected at Hillsboro Ledge, Boca Raton Florida and kept frozen until extraction. The methanolic extract was first fractionated on polymeric HP-20 resin using cyclic loading [<xref ref-type="bibr" rid="B6-marinedrugs-10-01662">6</xref>]. The HP-20 column was eluted with 800 mL fractions of (1) H<sub>2</sub>O, (2) 40% Me<sub>2</sub>CO/H<sub>2</sub>O, (3) 75% Me<sub>2</sub>CO/H<sub>2</sub>O and (4) Me<sub>2</sub>CO. The Me<sub>2</sub>CO fraction was then subjected to column chromatography on HP-20SS and normal phase HPLC to yield two new briareolate esters J (<bold>1</bold>) and K (<bold>2</bold>) and three known briareolate esters D (<bold>6</bold>), G (<bold>7</bold>), and M (<bold>4</bold>).</p>
      <fig id="marinedrugs-10-01662-f004" position="anchor">
        <label>Figure 4</label>
        <caption>
          <p><italic>Briareum asbestinum</italic>.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="marinedrugs-10-01662-g004.tif"/>
      </fig>
      <p>Briareolate ester J (<bold>1</bold>) was isolated as a colorless oil. The molecular formula of briareolate ester J (<bold>1</bold>), C<sub>33</sub>H<sub>50</sub>O<sub>9</sub>, was determined from the HRESIMS of the [M + Na]<sup>+</sup> ion at <italic>m</italic>/<italic>z</italic> 613.3346, 98 mass units higher than that of briareolate ester G (<bold>7</bold>). The presence of a ketone conjugated with two double bonds (α,β,γ,δ-unsaturated ketone) was indicated from a carbonyl carbon with a chemical shift of δ<sub>C</sub> 207 (C-9), and the C-C double bond carbons [δ<sub>C</sub> 146.3 (C-5), δ<sub>C</sub> 125.3 (C-6), δ<sub>C</sub> 140.9 (C-7), δ<sub>C</sub> 146.3 (C-8)]. The observation of absorption maxima at λ<sub>max</sub> = 287 and 225 nm in the UV spectrum was consistent with this assignment. NOE correlations observed from the olefinic proton H-6 to H-7 and H<sub>3</sub>-16, together with correlations from H-7 to both H-17 and H<sub>3</sub>-18, established the (<italic>Z</italic>,<italic>Z</italic>)-configuration of the dieneone and the <italic>s</italic>-<italic>cis</italic> conformation of the diene (<xref ref-type="fig" rid="marinedrugs-10-01662-f005">Figure 5</xref>). Additionally, the upfield chemical shift of the olefinic proton H-7 in <bold>1 </bold>at δ<sub>H</sub> 6.74 compared toδ<sub>H</sub> 7.64 in the (<italic>E</italic>,<italic>Z</italic>)-dieneone briareolate ester L (<bold>3</bold>), with the <italic>s</italic>-<italic>trans</italic> diene conformation, confirmed this assignment [<xref ref-type="bibr" rid="B5-marinedrugs-10-01662">5</xref>]. </p>
      <p>A close inspection of the <sup>1</sup>H and <sup>13</sup>C NMR data (<xref ref-type="table" rid="marinedrugs-10-01662-t001">Table 1</xref>) revealed the similarity of <bold>1</bold> to that of briareolate ester G (<bold>7</bold>), except that H-12 [δ<sub>H</sub> 4.89, br s] was shifted downfield by 1.24 ppm as compared with that of <bold>1</bold>. In addition, in the <sup>13</sup>C NMR spectrum the resonance of C-12 (δ<sub>C</sub> 73.7) was shifted downfield by 2.7 ppm and those of C-11 (δ<sub>C</sub> 38.4) and C-13 (δ<sub>C</sub> 30.2) were shifted upfield by 0.5 and 1.3 ppm, respectively, in comparison with those of <bold>1</bold> [<xref ref-type="bibr" rid="B4-marinedrugs-10-01662">4</xref>]. This suggested that the 12-hydroxy group of <bold>7</bold>, was replaced by a hexanoate group at C-12 in <bold>1</bold>, as observed in briareolate esters M (<bold>4</bold>) and N (<bold>5</bold>). The presence of the hexanoate group was confirmed by the NMR data [δ<sub>H</sub> 0.92 (3H, t, <italic>J</italic> = 8.0 Hz), <italic>ca.</italic> 1.31 (4H, overlapped), 1.63 (2H, overlapped), 2.32 (2H, m), δ<sub>C</sub> 17.6 (q), 24.0, 26.3, 33.0, and 36.1 (each t), 175.1 (CO)]. These assignments were confirmed by COSY, HSQC, and HMBC correlations similar to those observed for <bold>4</bold>, <bold>5</bold> and <bold>7</bold> (<xref ref-type="fig" rid="marinedrugs-10-01662-f005">Figure 5</xref>). The relative configuration of briareolate ester J (<bold>1</bold>) was determined to be the same as that of <bold>7</bold> from the similarity of proton-proton coupling constants and <sup>1</sup>H and <sup>13</sup>C chemical shifts together with NOE correlations observed in a ROESY experiment (<xref ref-type="fig" rid="marinedrugs-10-01662-f005">Figure 5</xref>). </p>
      <table-wrap id="marinedrugs-10-01662-t001" position="anchor">
        <object-id pub-id-type="pii">marinedrugs-10-01662-t001_Table 1</object-id>
        <label>Table 1</label>
        <caption>
          <p>NMR Spectroscopic Data for Briareolate Esters J (<bold>1</bold>) and K (<bold>2</bold>) <sup>a</sup>.</p>
        </caption>
        <table>
  <thead>
            <tr>
              <th rowspan="2" align="center" valign="middle">position</th>
              <th colspan="2" style="border-bottom:solid thin" align="center" valign="middle">1</th>
              <th colspan="2" style="border-bottom:solid thin" align="center" valign="middle">2</th>
            </tr>
            <tr>
              <th align="center" valign="middle">δ<sub>C</sub>, mult</th>
              <th align="center" valign="middle">δ<sub>H</sub> (
              <italic>J</italic> 
              in Hz)</th>
              <th align="center" valign="middle">δ<sub>C</sub>, mult</th>
              <th align="center" valign="middle">δ<sub>H</sub> (
              <italic>J</italic> in Hz)</th>
            </tr>
  </thead>
  <tbody>
            <tr>
              <td align="center" valign="middle">1</td>
              <td align="center" valign="middle">46.4, C</td>
              <td align="left" valign="middle"> </td>
              <td align="center" valign="middle">48.8, C</td>
              <td align="left" valign="middle"> </td>
            </tr>
            <tr>
              <td align="center" valign="middle">2</td>
              <td align="center" valign="middle">73.7, CH</td>
              <td align="left" valign="middle">5.17, br d (6.0)</td>
              <td align="center" valign="middle">80.5, CH</td>
              <td align="left" valign="middle">5.52, d (8.0)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">3α</td>
              <td align="center" valign="middle">31.3, CH<sub>2</sub></td>
              <td align="left" valign="middle">1.89, m</td>
              <td align="center" valign="middle">31.1, CH<sub>2</sub></td>
              <td align="left" valign="middle">2.31, m</td>
            </tr>
            <tr>
              <td align="center" valign="middle">3β</td>
              <td align="center" valign="middle"> </td>
              <td align="left" valign="middle">1.89, m</td>
              <td align="center" valign="middle"> </td>
              <td align="left" valign="middle">1.58, m</td>
            </tr>
            <tr>
              <td align="center" valign="middle">4α</td>
              <td align="center" valign="middle">30.2, CH<sub>2</sub></td>
              <td align="left" valign="middle">2.20, m</td>
              <td align="center" valign="middle">34.1, CH<sub>2</sub></td>
              <td align="left" valign="middle">2.53, dd (18.0, 8.0)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">4β</td>
              <td align="center" valign="middle"> </td>
              <td align="left" valign="middle">2.08, m</td>
              <td align="center" valign="middle"> </td>
              <td align="left" valign="middle">2.28, m</td>
            </tr>
            <tr>
              <td align="center" valign="middle">5</td>
              <td align="center" valign="middle">146.3, C</td>
              <td align="left" valign="middle"> </td>
              <td align="center" valign="middle">147.1, C</td>
              <td align="left" valign="middle"> </td>
            </tr>
            <tr>
              <td align="center" valign="middle">6</td>
              <td align="center" valign="middle">125.3, CH</td>
              <td align="left" valign="middle">6.12, br s</td>
              <td align="center" valign="middle">116.2, CH</td>
              <td align="left" valign="middle">5.47, br d (4.0)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">7</td>
              <td align="center" valign="middle">140.9, CH</td>
              <td align="left" valign="middle">6.74, br s</td>
              <td align="center" valign="middle">64.3, CH</td>
              <td align="left" valign="middle">4.42, br d (4.0)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">8</td>
              <td align="center" valign="middle">146.3, C</td>
              <td align="left" valign="middle"> </td>
              <td align="center" valign="middle">71.3, C</td>
              <td align="left" valign="middle"> </td>
            </tr>
            <tr>
              <td align="center" valign="middle">9</td>
              <td align="center" valign="middle">207.0, C</td>
              <td align="left" valign="middle"> </td>
              <td align="center" valign="middle">211.5, C</td>
              <td align="left" valign="middle"> </td>
            </tr>
            <tr>
              <td align="center" valign="middle">10</td>
              <td align="center" valign="middle">48.3, CH</td>
              <td align="left" valign="middle">3.79, d (12.0)</td>
              <td align="center" valign="middle">44.7, CH</td>
              <td align="left" valign="middle">3.06, d (12.0)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">11</td>
              <td align="center" valign="middle">38.4, CH</td>
              <td align="left" valign="middle">2.19, m</td>
              <td align="center" valign="middle">36.2, CH</td>
              <td align="left" valign="middle">2.34, m</td>
            </tr>
            <tr>
              <td align="center" valign="middle">12</td>
              <td align="center" valign="middle">73.7, CH</td>
              <td align="left" valign="middle">4.89, br s</td>
              <td align="center" valign="middle">72.6, CH</td>
              <td align="left" valign="middle">4.98, br s</td>
            </tr>
            <tr>
              <td align="center" valign="middle">13α</td>
              <td align="center" valign="middle">30.2,CH<sub>2</sub></td>
              <td align="left" valign="middle">2.05, m</td>
              <td align="center" valign="middle">29.9, CH<sub>2</sub></td>
              <td align="left" valign="middle">2.05, br d (16.0)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">13β</td>
              <td align="center" valign="middle"> </td>
              <td align="left" valign="middle">1.86, m </td>
              <td align="center" valign="middle"> </td>
              <td align="left" valign="middle">1.99, m </td>
            </tr>
            <tr>
              <td align="center" valign="middle">14</td>
              <td align="center" valign="middle">75.6, CH</td>
              <td align="left" valign="middle">4.68, br s</td>
              <td align="center" valign="middle">74.6, CH</td>
              <td align="left" valign="middle">4.69, br s</td>
            </tr>
            <tr>
              <td align="center" valign="middle">15</td>
              <td align="center" valign="middle">14.9, CH<sub>3</sub></td>
              <td align="left" valign="middle">1.19, s</td>
              <td align="center" valign="middle">12.8, CH<sub>3</sub></td>
              <td align="left" valign="middle">0.99, s</td>
            </tr>
            <tr>
              <td align="center" valign="middle">16</td>
              <td align="center" valign="middle">26.3, CH<sub>3</sub></td>
              <td align="left" valign="middle">2.19, s</td>
              <td align="center" valign="middle">26.8, CH<sub>3</sub></td>
              <td align="left" valign="middle">1.75, s</td>
            </tr>
            <tr>
              <td align="center" valign="middle">17</td>
              <td align="center" valign="middle">46.4, CH</td>
              <td align="left" valign="middle">3.45, q (8.0)</td>
              <td align="center" valign="middle">40.8, CH</td>
              <td align="left" valign="middle">2.39, q (8.0)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">18</td>
              <td align="center" valign="middle">19.8, CH<sub>3</sub></td>
              <td align="left" valign="middle">1.32, d (8.0)</td>
              <td align="center" valign="middle">13.5, CH<sub>3</sub></td>
              <td align="left" valign="middle">1.29, d (8.0)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">19</td>
              <td align="center" valign="middle">176.7, C</td>
              <td align="left" valign="middle"> </td>
              <td align="center" valign="middle">175.3, C</td>
              <td align="left" valign="middle"> </td>
            </tr>
            <tr>
              <td align="center" valign="middle">20</td>
              <td align="center" valign="middle">17.6, CH<sub>3</sub></td>
              <td align="left" valign="middle">0.79, d (8.0)</td>
              <td align="center" valign="middle">16.8, CH<sub>3</sub></td>
              <td align="left" valign="middle">0.75, d (8.0)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">OMe</td>
              <td align="center" valign="middle">52.8, CH<sub>3</sub></td>
              <td align="left" valign="middle">3.62, s</td>
              <td align="center" valign="middle">52.5, CH<sub>3</sub></td>
              <td align="left" valign="middle">3.61, s</td>
            </tr>
            <tr>
              <td align="center" valign="middle">ester at C-2</td>
              <td align="center" valign="middle">175.1, C</td>
              <td align="left" valign="middle"> </td>
              <td align="center" valign="middle">174.3, C</td>
              <td align="left" valign="middle"> </td>
            </tr>
            <tr>
              <td align="center" valign="middle"> </td>
              <td align="center" valign="middle">37.7, CH<sub>2</sub></td>
              <td align="left" valign="middle">2.19, m</td>
              <td align="center" valign="middle">37.9, CH<sub>2</sub></td>
              <td align="left" valign="middle">2.25, m</td>
            </tr>
            <tr>
              <td align="center" valign="middle"> </td>
              <td align="center" valign="middle">19.2, CH<sub>2</sub></td>
              <td align="left" valign="middle">1.57, m</td>
              <td align="center" valign="middle">19.7, CH<sub>2</sub></td>
              <td align="left" valign="middle">1.60, m</td>
            </tr>
            <tr>
              <td align="center" valign="middle"> </td>
              <td align="center" valign="middle">14.5, CH<sub>3</sub></td>
              <td align="left" valign="middle">0.92, t (8.0)</td>
              <td align="center" valign="middle">14.5, CH<sub>3</sub></td>
              <td align="left" valign="middle">0.93, t (8.0)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">ester at C-12</td>
              <td align="center" valign="middle">175.1, C</td>
              <td align="left" valign="middle"> </td>
              <td align="center" valign="middle">175.4, C</td>
              <td align="left" valign="middle"> </td>
            </tr>
            <tr>
              <td align="center" valign="middle"> </td>
              <td align="center" valign="middle">36.1, CH<sub>2</sub></td>
              <td align="left" valign="middle">2.32, m</td>
              <td align="center" valign="middle">35.9 CH<sub>2</sub></td>
              <td align="left" valign="middle">2.37, m</td>
            </tr>
            <tr>
              <td align="center" valign="middle"> </td>
              <td align="center" valign="middle">26.3, CH<sub>2</sub></td>
              <td align="left" valign="middle">1.63, m</td>
              <td align="center" valign="middle">26.4 CH<sub>2</sub></td>
              <td align="left" valign="middle">1.64, m</td>
            </tr>
            <tr>
              <td align="center" valign="middle"> </td>
              <td align="center" valign="middle">33.0, CH<sub>2</sub></td>
              <td align="left" valign="middle">1.31, m</td>
              <td align="center" valign="middle">33.0 CH<sub>2</sub></td>
              <td align="left" valign="middle">1.33, m</td>
            </tr>
            <tr>
              <td align="center" valign="middle"> </td>
              <td align="center" valign="middle">24.0, CH<sub>2</sub></td>
              <td align="left" valign="middle">1.31, m</td>
              <td align="center" valign="middle">24.0 CH<sub>2</sub></td>
              <td align="left" valign="middle">1.33, m</td>
            </tr>
            <tr>
              <td align="center" valign="middle"> </td>
              <td align="center" valign="middle">17.6, CH<sub>3</sub></td>
              <td align="left" valign="middle">0.92, t (8.0)</td>
              <td align="center" valign="middle">14.8 CH<sub>3</sub></td>
              <td align="left" valign="middle">0.95, t (8.0)</td>
            </tr>
            <tr>
              <td align="center" valign="middle">ester at C-14</td>
              <td align="center" valign="middle">172.1, C</td>
              <td align="left" valign="middle"> </td>
              <td align="center" valign="middle">172.6, C</td>
              <td align="left" valign="middle"> </td>
            </tr>
            <tr>
              <td align="center" valign="middle"> </td>
              <td align="center" valign="middle">22.1, CH<sub>3</sub></td>
              <td align="left" valign="middle">1.98, s</td>
              <td align="center" valign="middle">22.3 CH<sub>3</sub></td>
              <td align="left" valign="middle">1.99, s</td>
            </tr>
  </tbody>
        </table>
    <table-wrap-foot>
      <fn>
        <p><sup>a</sup> In CD<sub>3</sub>OD, 400 MHz for <sup>1</sup>H and 100 MHz for <sup>13</sup>C NMR.</p>
      </fn>
    </table-wrap-foot>	  
	  </table-wrap>
      <fig id="marinedrugs-10-01662-f005" position="anchor">
        <label>Figure 5</label>
        <caption>
          <p>Selected 2D NMR correlations for briareolate ester J (<bold>1</bold>).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="marinedrugs-10-01662-g005.tif"/>
      </fig>
      <p>Briareolate ester K (<bold>2</bold>) was isolated as a colorless oil. The molecular formula of briareolate ester K (<bold>2</bold>), C<sub>33</sub>H<sub>50</sub>O<sub>10</sub>, was determined from the HRESIMS of the [M + Na]<sup>+</sup> ion at <italic>m</italic>/<italic>z</italic> 629.3291, one more oxygen atom than that of briareolate ester J (<bold>1</bold>). A comparison of the <sup>1</sup>H and <sup>13</sup>C NMR data (<xref ref-type="table" rid="marinedrugs-10-01662-t001">Table 1</xref>) revealed that <bold>2</bold> was similar to <bold>1</bold>, except that the NMR signals for the C-7–C-8 double bond were missing in the NMR spectra of <bold>2</bold>, and instead, resonances for an epoxide were observed in the <sup>1</sup>H NMR (δ 4.42, H-6) and <sup>13</sup>C NMR [δ<sub>C</sub> 64.3 (s); 71.3 (d)] spectra indicating oxidation of the C-7–C-8 double bond to be an epoxide. HMBC correlations from the oxygenated methine signal at δ 4.42 (H-7) to C-5 (δ 147.1) and C-6 (δ 116.2) of the trisubstituted double bond, and to C-8 (δ 71.3) and C-9 (δ 211.5) are consistent with this assignment. Additional HMBC correlations observed from H-17 to C-7, C-8 and C-9 confirmed this assignment (<xref ref-type="fig" rid="marinedrugs-10-01662-f006">Figure 6</xref>). </p>
      <fig id="marinedrugs-10-01662-f006" position="anchor">
        <label>Figure 6</label>
        <caption>
          <p>Selected NMR correlations for briareolate ester K (<bold>2</bold>).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="marinedrugs-10-01662-g006.tif"/>
      </fig>
      <p>The relative configuration of briareolate ester K (<bold>2</bold>) was determined to be identical to that of <bold>1</bold> on the basis of NOE enhancements revealed in a series of 1D NOESY experiments (<xref ref-type="fig" rid="marinedrugs-10-01662-f006">Figure 6</xref>). The configuration of the C-7/8 epoxide was determined from NOE enhancements observed between H-7 and H-2 together with NOE enhancements observed from H-6 to H-17 which placed H-7 on the inside of the 10-membered ring and indicated the <italic>trans</italic> orientation of the epoxide. This assignment is consistent with that of briareolate ester D (<bold>6</bold>) whose structure was assigned on the basis of X-ray crystallography [<xref ref-type="bibr" rid="B4-marinedrugs-10-01662">4</xref>]. </p>
      <p>Compounds <bold>1</bold> and <bold>2</bold> were evaluated for cell growth inhibitory activities against human embryonic stem cells (BG02) using a 96-well plate real-time cell electronic sensing (RT-CES) system [<xref ref-type="bibr" rid="B7-marinedrugs-10-01662">7</xref>]. Briareolate ester K (<bold>2</bold>) showed weak growth inhibition against BG02 cells with an EC<sub>50</sub> value of 40 µM. No inhibitory activity was detected for briareolate ester J (<bold>1</bold>) at 40 µM. Previously the (<italic>E</italic>,<italic>Z</italic>)-dienone containing briareolate esters L (<bold>3</bold>) and M (<bold>4</bold>) were found to have growth inhibition against both the BG02 and a pancreatic cancer cell line (BxPC-3) cells with EC<sub>50</sub> values of 2.4 and 9.3 µM, respectively for <bold>3</bold>, and 8.0 µM against BG02 cells and only cytostatic effects at 13.0 and 17.0 µM against the BxPC-3 cells for <bold>4 </bold>[<xref ref-type="bibr" rid="B5-marinedrugs-10-01662">5</xref>]. No growth inhibition was found for the briareolate esters B, C, G (<bold>7</bold>), and N (<bold>5</bold>). The absence of significant growth inhibition activity for the (<italic>Z</italic>,<italic>Z</italic>)-dieneone compound <bold>1</bold> and the epoxide containing compound <bold>2</bold> further confirms the importance of the (<italic>E</italic>,<italic>Z</italic>)-dieneone for biological activity.</p>
    </sec>
    <sec>
      <title>3. Experimental Section</title>
      <sec sec-type="methods">
        <title>3.1. General Experimental Procedures</title>
        <p>Optical rotations were measured on a Jasco P-2000 polarimeter (<italic>c</italic>: g/100 mL) at 589 nm. UV spectra were obtained on a Perkin-Elmer Lambda EZ 210 UV-vis spectrophotometer. IR spectra were recorded on a Thermo Electronic Corporation Nicolet IR-100 spectrophotometer. All NMR spectra were recorded on a Varian MercuryPlus 400 spectrometer. All chemical shifts (δ) were referenced internally to the residual solvent peak (CD<sub>3</sub>OD: <sup>1</sup>H, δ 3.30; <sup>13</sup>C, δ 49.0; CDCl<sub>3</sub>: <sup>1</sup>H 7.26 ppm; <sup>13</sup>C 77.0 ppm). Short- and long-range <sup>1</sup>H–<sup>13</sup>C correlations were determined with gradient-enhanced inverse-detected HSQC and HMBC experiments respectively. NOE correlations were detected with NOESY or ROESY experiments with a 0.5 s mixing time. The high-resolution ESI mass spectra were obtained using an Agilent 6210 LC-TOF mass spectrometer at the Mass Spectrometer Facility at the University of Florida, Gainesville, Florida. HPLC purifications were performed on Beckman System Gold HPLC system with a 168 UV detector and a SEDEX 85 (Sedere) evaporative light scattering detector. Thin layer chromatography (TLC) analyses were performed using Merck Kieselgel (Aufoilen) 60 F<sub>254</sub> plates. TLC plates were visualized by spraying with 1:1 MeOH:H<sub>2</sub>SO<sub>4</sub>.</p>
      </sec>
      <sec>
        <title>3.2. Animal Material</title>
        <p>The gorgonian <italic>Briareum asbesinum</italic> was collected by hand using SCUBA at a depth of 45–50 ft from Hillsboro Ledge, Boca Raton Florida. The specimen was immediately frozen and kept at −20 °C until extraction. A voucher specimen has been deposited in the Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton Florida (FAU02-010). </p>
      </sec>
      <sec>
        <title>3.3. Extraction and Isolation</title>
        <p>The sample of <italic>Briareum asbestinum</italic> (500 g wet wt.), were extracted with MeOH (3 × 800 mL) for 24 h. The third, second and then the first extracts were passed through a column of HP-20 resin (2.5 × 25 cm) equilibrated with MeOH. The combined eluents was diluted with H<sub>2</sub>O (2.5 L) and passed again through the column. The column was eluted with 800 mL fractions of: (1) H<sub>2</sub>O, (2) 40% Me<sub>2</sub>CO/H<sub>2</sub>O, (3) 75% Me<sub>2</sub>CO/H<sub>2</sub>O and (4) Me<sub>2</sub>CO. Fraction 4 was concentrated to dryness and was subjected to column chromatography on HP-20SS resin eluting with increasing concentrations of MeCN in H<sub>2</sub>O (40%–100%). A late eluting fraction was further subjected to semi-preparative silica gel HPLC (Luna 5 µm; 10 × 250 mm; 4 mL/min; 5%–50% EtOAc/Hexane over 30 min) to give <bold>1</bold> (6.0 mg), <bold>2</bold> (10.0 mg), <bold>4</bold> (10.0 mg), <bold>6</bold> (10.0 mg) and <bold>7</bold> (5.0 mg). </p>
        <p>Briareolate ester J (<bold>1</bold>): Colorless oil; [α]<sup>25</sup><sub>D</sub> −19 (<italic>c</italic> 0.05, MeOH); UV (MeOH) λ<sub>max</sub> 225 nm (ε 2711), 287 (ε 1713); IR (MeOH) ν<sub>max</sub> 2956, 2867, 1737, 1641, 1454, 1371 cm<sup>−1</sup>; <sup>1</sup>H and <sup>13</sup>C NMR data, see <xref ref-type="table" rid="marinedrugs-10-01662-t001">Table 1</xref>; HRESIMS <italic>m/z</italic> 613.3346 [M + Na]<sup>+</sup> (calcd. for C<sub>33</sub>H<sub>50</sub>O<sub>9</sub>Na, 613.3353).</p>
        <p>Briareolate ester K (<bold>2</bold>): Colorless oil; [α]<sup>25</sup><sub>D</sub> −8 (<italic>c</italic> 0.05, MeOH); IR (MeOH) ν<sub>max</sub> 2951, 2869, 1742, 1454, 1367 cm<sup>−1</sup>; <sup>1</sup>H and <sup>13</sup>C NMR data, see <xref ref-type="table" rid="marinedrugs-10-01662-t001">Table 1</xref>; HRESIMS <italic>m/z</italic> 629.3291 [M + Na]<sup>+</sup> (calcd. for C<sub>33</sub>H<sub>50</sub>O<sub>10</sub>Na, 629.3302).</p>
      </sec>
      <sec>
        <title>3.4. Cell Culture</title>
        <p>BG02 hESCs were grown in defined medium, containing 10 ng/mL HRG1β (Peprotech), 10 ng/mL ActA (R&amp;D Systems), 200 ng/mL LR<sup>3</sup>-IGF1 (JRH Biosciences), and 8 ng/mL FGF2 (Sigma or R&amp;D Systems). Cultures were passaged with Accutase (Innovative Cell Technologies) and plated on tissue culture flasks coated with growth factor-reduced matrigel (BD Biosciences) diluted 1:200, as described by Robins and Schulz [<xref ref-type="bibr" rid="B8-marinedrugs-10-01662">8</xref>].</p>
      </sec>
      <sec>
        <title>3.5. RT-CES Cytotoxicity Assays</title>
        <p>The xCELLigence real-time impedance system (Roche) was used to monitor the effects of compounds on cells [<xref ref-type="bibr" rid="B7-marinedrugs-10-01662">7</xref>]. BG02 cells were plated at 1 × 10<sup>4</sup> cells/well in matrigel coated plates. The culture was placed in the reader station under standard humidified conditions and incubated at 37 °C with 5% CO<sub>2</sub>. The media was changed every 24 h and impedance was measured every 15 min for 3 days. Compounds were added to quadruplicate wells 24 h after plating. Vincristine was used as a positive control for cytotoxicity, and DMSO alone was used as a negative control. Cell index plots were normalized immediately prior to addition of compound, and EC<sub>50</sub> values were generated using the xCELLigence analysis software RTCA ver 1.1 after 2 days of treatment.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <title>4. Conclusions</title>
      <p>Two new briarane diterpenoids briareolate esters J (<bold>1</bold>) and K (<bold>2</bold>), along with three known compounds were isolated from the methanolic extract of <italic>B. asbestinum</italic> collected off the coast of Boca Raton, Florida. The compounds were identified from screening semi-purified and pre-fractioned extract libraries against hESCs and briareolate ester K (<bold>2</bold>) containing a <italic>trans</italic> C-7/8 epoxide was found to exhibit weak growth inhibition activity against human embryonic stem cells (BG02). The lack of biological activity for briaranes <bold>1</bold> and <bold>2</bold> further confirmed the requirement of the α,β,γ,δ-unsaturated ketone in conjunction with the double bond configuration for biological activity.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>This research was supported by the National Institutes of Health Grants P41GM079597 and P01GM085354. We thank T. Vansach (FAU) and R. Barrett (FAU) for assistance in collection of <italic>Briareum asbestinum</italic>.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1-marinedrugs-10-01662">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berrue</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Kerr</surname>
              <given-names>R.G.</given-names>
            </name>
          </person-group>
          <article-title>Diterpenes from gorgonian corals</article-title>
          <source>Nat. Prod. Rep.</source>
          <year>2009</year>
          <volume>26</volume>
          <fpage>681</fpage>
          <lpage>710</lpage>
        <pub-id pub-id-type="doi">10.1039/b821918b</pub-id><pub-id pub-id-type="pmid">19387501</pub-id></citation>
      </ref>
      <ref id="B2-marinedrugs-10-01662">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maharaj</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Mootoo</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Lough</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>McLean</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>W.F.</given-names>
            </name>
            <name>
              <surname>Tinto</surname>
              <given-names>W.F.</given-names>
            </name>
          </person-group>
          <article-title>Methyl briareolate, the first briarein diterpene containing a C-19 methyl ester</article-title>
          <source>Tetrahedron Lett.</source>
          <year>1992</year>
          <volume>33</volume>
          <fpage>7761</fpage>
          <lpage>7764</lpage>
        <pub-id pub-id-type="doi">10.1016/0040-4039(93)88039-L</pub-id></citation>
      </ref>
      <ref id="B3-marinedrugs-10-01662">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dookran</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Maharaj</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Mootoo</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Ramsewak</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>McLean</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>W.F.</given-names>
            </name>
            <name>
              <surname>Tinto</surname>
              <given-names>W.F.</given-names>
            </name>
          </person-group>
          <article-title>Briarane and asbestinane diterpenes from <italic>Briareum asbestinum</italic></article-title>
          <source>Tetrahedron</source>
          <year>1994</year>
          <volume>50</volume>
          <fpage>1983</fpage>
          <lpage>1992</lpage>
        </citation>
      </ref>
      <ref id="B4-marinedrugs-10-01662">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mootoo</surname>
              <given-names>B.S.</given-names>
            </name>
            <name>
              <surname>Ramsewak</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Tinto</surname>
              <given-names>W.F.</given-names>
            </name>
            <name>
              <surname>Lough</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>McLean</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>W.F.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Further briareolate esters and briareolides from the Caribbean gorgonian octocoral <italic>Briareum asbestinum</italic></article-title>
          <source>Tetrahedron</source>
          <year>1996</year>
          <volume>52</volume>
          <fpage>9953</fpage>
          <lpage>9962</lpage>
        <pub-id pub-id-type="doi">10.1016/0040-4020(96)00528-5</pub-id></citation>
      </ref>
      <ref id="B5-marinedrugs-10-01662">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>T.C.</given-names>
            </name>
            <name>
              <surname>Sherrer</surname>
              <given-names>E.S.</given-names>
            </name>
            <name>
              <surname>McLean</surname>
              <given-names>A.B.</given-names>
            </name>
            <name>
              <surname>Robins</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>L.M.</given-names>
            </name>
          </person-group>
          <article-title>Bioactive diterpenoid containing a reversible “spring-loaded” (<italic>E,Z</italic>)-dieneone michael acceptor</article-title>
          <source>Org. Lett.</source>
          <year>2011</year>
          <volume>13</volume>
          <fpage>3920</fpage>
          <lpage>3923</lpage>
        <pub-id pub-id-type="doi">10.1021/ol201443k</pub-id><pub-id pub-id-type="pmid">21749084</pub-id></citation>
      </ref>
      <ref id="B6-marinedrugs-10-01662">
        <label>6.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Houssen</surname>
              <given-names>W.E.</given-names>
            </name>
            <name>
              <surname>Jaspars</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Methods in Biotechnology</article-title>
          <source>Natural Products Isolation</source>
          <edition>2nd</edition>
          <person-group person-group-type="editor">
            <name>
              <surname>Sarker</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Latif</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>A.I.</given-names>
            </name>
          </person-group>
          <publisher-name>Humana Press</publisher-name>
          <publisher-loc>Totowa, NJ, USA</publisher-loc>
          <year>2006</year>
          <volume>20</volume>
          <fpage>353</fpage>
          <lpage>391</lpage>
        </citation>
      </ref>
      <ref id="B7-marinedrugs-10-01662">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Solly</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Strulovici</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays</article-title>
          <source>Assay Drug Dev. Technol.</source>
          <year>2004</year>
          <volume>2</volume>
          <fpage>363</fpage>
          <lpage>372</lpage>
        <pub-id pub-id-type="doi">10.1089/adt.2004.2.363</pub-id><pub-id pub-id-type="pmid">15357917</pub-id></citation>
      </ref>
      <ref id="B8-marinedrugs-10-01662">
        <label>8.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Robins</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>T.C.</given-names>
            </name>
          </person-group>
          <article-title>Media and Extra Cellular Matrix Requirements for Large-Scale ESC Growth</article-title>
          <source>Emerging Technology Platforms for Stem Cells</source>
          <person-group person-group-type="editor">
            <name>
              <surname>Lakshmipathy</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Chesnut</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Thyagarajan</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <publisher-name>Wiley-Blackwell</publisher-name>
          <publisher-loc>Oxford, UK</publisher-loc>
          <year>2009</year>
          <fpage>251</fpage>
          <lpage>274</lpage>
        </citation>
      </ref>
    </ref-list>
	<fn-group>
	 <fn>
	   <p><italic>Samples Availability:</italic> Available from the authors.</p>
	 </fn>
	</fn-group>
<app-group>
    <app>
        <title>Supplementary Files</title>
        <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" id="marinedrugs-10-01662-s001" xlink:href="marinedrugs-10-01662-s001.pdf">
        <label>Supplementary File 1:</label>
            <caption>
                <p>PDF-Document (PDF, 681 KB)</p>
            </caption>
        </supplementary-material>
    </app>
</app-group>	
  </back>
  
</article>
